Skip to main content
. 2022 Sep 1;9(2):lsac022. doi: 10.1093/jlb/lsac022

Table 1.

Humira Patent Assertions.

Biosimilar of Humira® (adalimumab) Number of patents listed on 3A Number of patents included in first wave litigation Number of patents included in second wave litigation
Amgen (Amgevita) 61 10 Case settled
Alvotech (AVT02) 63 4 58
Samsung (Hadlima) Pre-litigation settlement
Pfizer (Abrilada) Pre-litigation settlement
Mylan (Hulio) Pre-litigation settlement